Rob Finn

Rob Finn is an accomplished professional with extensive experience in the healthcare and technology sectors. Currently serving as Managing Director at Press Ganey since January 2024, Rob has previously held significant roles including Strategic Account Executive at GHX and Vice President of Business Development at Trellis Rx, where expertise focused on enhancing patient experiences with specialty medication therapy. Rob's career also includes leadership positions at Omnicell, Aesynt, McKesson Provider Technologies, Myriad Genetics, and an engineering role at Herman Miller. Rob holds a degree from California State University-Sacramento.